{
  "id": 1769615468966,
  "seqId": 140,
  "title": "Submacular (Subfoveal) Haemorrhage: Management & Outcomes",
  "summary": "A rare but devastating complication resulting in photoreceptor death and permanent visual loss. This condition requires urgent identification and intervention, as the natural history is poor and surgical outcomes are heavily dependent on the duration of the haemorrhage.",
  "date": "2026-01-28T15:51:08.966Z",
  "data": {
    "title": "Submacular (Subfoveal) Haemorrhage: Management & Outcomes",
    "summary": "A rare but devastating complication resulting in photoreceptor death and permanent visual loss. This condition requires urgent identification and intervention, as the natural history is poor and surgical outcomes are heavily dependent on the duration of the haemorrhage.",
    "summary_illustration": "<svg viewBox='0 0 100 100' xmlns='http://www.w3.org/2000/svg'><circle cx='50' cy='50' r='45' fill='none' stroke='#0047AB' stroke-width='2'/><path d='M20 50 Q 50 80 80 50' fill='none' stroke='#0047AB' stroke-width='2'/><circle cx='50' cy='50' r='10' fill='#D32F2F' opacity='0.8'/><path d='M30 50 L70 50' stroke='#D32F2F' stroke-width='4' stroke-linecap='round'/><text x='50' y='92' text-anchor='middle' font-size='6' font-family='Arial' fill='#0047AB'>Subretinal Space</text></svg>",
    "sections": [
      {
        "title": "The Pathology of Vision Loss",
        "icon": "biotech",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "purple",
        "content": {
          "center": "Submacular Haemorrhage",
          "branches": [
            "Rare but devastating complication",
            "Causes Photoreceptor death",
            "Leads to Permanent visual loss",
            "Toxic effect of iron release",
            "Physical barrier to diffusion",
            "Subsequent fibrotic changes worsen vision"
          ]
        }
      },
      {
        "title": "Primary Etiologies",
        "icon": "emergency",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Choroidal Neovascularization (CnV)",
          "Retinal Macroaneurysm (Rare)",
          "Angioid Streaks (Rare)",
          "Trauma (Rare)"
        ]
      },
      {
        "title": "Clinical Features",
        "icon": "visibility",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Sudden painless loss of vision",
          "Presence of Drusen",
          "Known Age-related Macular Degeneration (AmD)",
          "Risk factors for macroaneurysm",
          "Large haemorrhage in the subretinal space"
        ]
      },
      {
        "title": "Diagnostic Investigations",
        "icon": "microscope",
        "type": "table",
        "layout": "full_width",
        "color_theme": "green",
        "content": {
          "headers": [
            "Investigation",
            "Clinical Value & Details"
          ],
          "rows": [
            [
              "OCT (Optical Coherence Tomography)",
              "Helps identify haemorrhage location. Crucial to distinguish subretinal from preretinal or sub-ILm haemorrhage (which both have a better natural history)."
            ],
            [
              "FFA (Fundus Fluorescein Angiography)",
              "Helps identify the cause, particularly associated macroaneurysms, provided they are not covered by the haemorrhage."
            ]
          ]
        }
      },
      {
        "title": "Management Landscape",
        "icon": "settings_suggest",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "yellow",
        "content": "One of the management issues is the variation and multitude of treatment regimes available."
      },
      {
        "title": "Treatment Options",
        "icon": "medication",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "blue",
        "content": [
          "Intravitreal injections: anti-VEGF only.",
          "Intravitreal injections: recombinant tissue plasminogen activator (rtPA) only.",
          "Intravitreal injections: rtPA in addition to anti-VEGF.",
          "Vitrectomy with subretinal or intravitreal injection of rtPA and gas."
        ]
      },
      {
        "title": "Pneumatic Displacement Protocol",
        "icon": "airway",
        "type": "process",
        "layout": "full_width",
        "color_theme": "green",
        "content": [
          "Step 1: Intravitreal injection of 0.3mL of C3F8 gas.",
          "Step 2: Optional addition of intravitreal rtPA (50–100 micrograms) and/or anti-VEGF.",
          "Step 3: Posturing - This is key to moving the lysed haemorrhage away from the fovea."
        ]
      },
      {
        "title": "Complications of Pneumatic Displacement",
        "icon": "warning",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Raised IoP (if AC paracentesis is not performed during multiple intravitreal therapies)",
          "Cataract due to the use of gas",
          "Vitreous haemorrhage (due to blood displacement into the vitreous cavity)",
          "Patients must be warned about the risk of vitreous haemorrhage"
        ]
      },
      {
        "title": "Prognosis & Timing",
        "icon": "history",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "Natural history of this condition is devastating.",
          "Main outcome factor: Duration of haemorrhage.",
          "If haemorrhage is >2 weeks, visual outcome after surgery is reduced.",
          "Consensus: Pneumatic displacement + rtPA + subsequent anti-VEGF (if indicated) may be most effective."
        ]
      },
      {
        "title": "Clinical Evidence & References",
        "icon": "menu_book",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "purple",
        "content": "23. Submacular Surgery Trials (SST) Research Group. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology. 2004;111:1993–2006. \n\n24. Bae k et al. optical coherence tomographic features and prognosis of pneumatic displacement for submacular hemorrhage. PLoS ONE. 2016;11:e0168474."
      }
    ],
    "chapterId": "uncategorized"
  },
  "chapterId": "investigations",
  "_newlyImported": 1769615468966,
  "communityId": "sub_1769614749293_q76894bu3lv1vr",
  "communityAuthor": "hh",
  "communityDate": "2026-01-28T15:39:09.293Z",
  "_chapterUpdated": 1769615873549,
  "_serverSynced": true
}